SCHEMBL4971996

SCHEMBL4971996

N[C@@H](CC(F)(F)F)C(=O)NC(c1ccc(F)cc1)[C@H](c1ccccc1)c1cc(F)cc(OC(F)(F)C(F)F)c1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CETP P11597 14/20 0.37
KCNH2 Q12809 4/20 0.36
SCN9A Q15858 1/20 0.36
HTRA1 Q92743 1/20 0.33
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
CNR1 P21554 2/20 0.33
CNR2 P34972 2/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
CRHBP P24387 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
CRHR2 Q13324 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4971037 1.00 CETP (0.37) CETPKCNH2SCN9AHTRA1CYP1A2
SCHEMBL3060774 0.80 CETP (0.37) CETPCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5010413 0.78 MAPT (0.32) CETPKCNH2CYP1A2CYP3A4CYP2D6
SCHEMBL758889 0.78 IDO1 (0.35) CETPKCNH2CYP1A2CYP3A4CYP2D6
SCHEMBL4971705 0.74 SLC6A9 (0.40) CETPKCNH2SCN9A
SCHEMBL758655 0.72 CETP (0.62) CETPKCNH2
SCHEMBL758656 0.72 CETP (0.62) CETPKCNH2
SCHEMBL758720 0.72 CETP (0.62) CETPKCNH2
SCHEMBL762000 0.71 EPHX2 (0.47) CETPCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL4968561 0.71 SLC6A9 (0.40) CETPKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1954668-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS Brystol-Myers Squibb Company (US) 2008-08-13 EP disclosed
WO-2007062308-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-05-31 WO disclosed